<code id='462E0FDF86'></code><style id='462E0FDF86'></style>
    • <acronym id='462E0FDF86'></acronym>
      <center id='462E0FDF86'><center id='462E0FDF86'><tfoot id='462E0FDF86'></tfoot></center><abbr id='462E0FDF86'><dir id='462E0FDF86'><tfoot id='462E0FDF86'></tfoot><noframes id='462E0FDF86'>

    • <optgroup id='462E0FDF86'><strike id='462E0FDF86'><sup id='462E0FDF86'></sup></strike><code id='462E0FDF86'></code></optgroup>
        1. <b id='462E0FDF86'><label id='462E0FDF86'><select id='462E0FDF86'><dt id='462E0FDF86'><span id='462E0FDF86'></span></dt></select></label></b><u id='462E0FDF86'></u>
          <i id='462E0FDF86'><strike id='462E0FDF86'><tt id='462E0FDF86'><pre id='462E0FDF86'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:5128
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Diabetes management: Digital health tools fall short, study says
          Diabetes management: Digital health tools fall short, study says

          AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc